Autonomous driving paper index
Eliminate, Reprogram, and Rebuild
One-line summary
We propose that the centriole - through active regulatory mechanisms (DID-RNA, CAMC remodeling, NANOG sequestration, cilium-dependent signaling) - actively maintains the differentiated state and thus constitutes a somatic barrier to sustained totipotency.
Engineering notes
Key topics: autonomous driving, prediction, control. See the paper for implementation details and experimental results.
Chinese explanation / 中文解读
中文解读待补充：本站会优先为端到端自动驾驶、BEV感知、3D目标检测、轨迹预测、路径规划、LiDAR感知等高价值论文补充中文说明。
Original abstract
Background. Transient totipotent-like states (8CLCs, 2CLCs) can now be induced from pluripotent stem cells through transcription factor expression (DUX4) or chemical chromatin remodeling (TLSCs) - without centriole manipulation. Stable, self-renewing totipotent cells have been achieved from ESCs. Yet no method has produced sustained totipotency from a fully differentiated somatic cell. Why? Hypothesis. We propose that the centriole - through active regulatory mechanisms (DID-RNA, CAMC remodeling, NANOG sequestration, cilium-dependent signaling) - actively maintains the differentiated state and thus constitutes a somatic barrier to sustained totipotency. It is not the only barrier: TLSCs prove that the chromatin barrier can be overcome chemically. But somatic cells carry the burden of having traversed the differentiation ratchet - old centrioles accumulated through asymmetric inheritance - that ESCs do not. Entropy is not the barrier. Entropy accumulates passively in all structures (Second Law of Thermodynamics) and DEGRADES the centriole’s active regulatory function over time. When that function fails, the cell does not revert to totipotency - it becomes malignant. The barrier to totipotency is the centriole’s active maintenance of the differentiated state; entropy is what breaks the barrier, not what creates it. Irreversible differentiation means the irreversible shutdown of some gene regulatory networks and the activation of others. In naive cells (ESCs, iPSCs), gene networks are open - all programs remain accessible. TLSCs succeed without centriole manipulation because they start from this open state. Somatic cells have closed networks: genes required for totipotency are silenced, often at the chromatin level, but also - we propose - physically, through the centriolar ratchet. This additional hardware burden, a consequence of differentiation history rather than chronological age, may explain why somatic reprogramming arrests at the 8CLC stage - cells touch totipotency but cannot hold it. The centriole as a differentiation ratchet. The centriole is a material structure that ages passively with time in all cells - dividing and post-mitotic alike. Multicellular animals accumulate old centrioles in stem cells through asymmetric inheritance rather than eliminating them. This accumulation is the physical basis of irreversible differentiation: the ratchet permits forward movement along differentiation trajectories but forbids spontaneous reversal. Aging is the price of true differentiation. Plants, which lack centrioles in somatic cells, employ modulation (reversible differentiation). Prediction. Centriole elimination combined with totipotency factors (DUX4 + TPRX1) will convert non-totipotent 8CLCs into stable, self-renewing totipotent cells - defined as >50% MERVL+ after 10 passages, with competence for trophectoderm differentiation. The centriole is not a lock on totipotency per se - it is a lock on the STABILITY of totipotency in differentiated cells that have passed through the ratchet. Evidence. We present a meta-analysis of four convergent evidence streams: (1) centriole elimination during oogenesis across five model organisms, (2) the molecular distinction between pluripotency and totipotency programs, (3) the 2CLC/8CLC/TLSC literature establishing that totipotency can be accessed - but not sustained - from somatic cells, and (4) the centriole’s role as a conditional entropy accumulator in the MCARA framework. Experimental Design. Three-phase protocol: Phase 1 - Eliminate (PLK4 PROTAC/RP-1664-mediated centriole removal), Phase 2 - Reprogram (Tet-On DUX4 + TPRX1), Phase 3 - Rebuild (re-expression of de novo centriole biogenesis factors: PLK4, SAS-6, STIL, CPAP). Two species: Phase 1-2 in human fibroblasts (~$137K), Phase 2-3 with tetraploid complementation in mouse cells (~$126K). Critical controls: OSKM + p53/p38 inhibitors without elimination; elimination + neural factors (lock vs sensor discrimination); elimination + TLSC protocol. Significance. If confirmed, this would demonstrate that the centriole is a somatic barrier to sustained totipotency - not the only barrier, but one that must be addressed when starting from aged, differentiated cells. The implications span regenerative medicine, aging reversal, and the understanding of why somatic cells cannot spontaneously dedifferentiate.
Links and sources
Need this topic turned into a technical roadmap?
Full Self Driving can prepare a custom autonomous driving literature review, code map, dataset map, and B2B technology assessment.
Request B2B research
Comments